FibroBiologics (FBLG) vs Jaguar Health (JAGX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Jaguar Health is the larger company by market cap ($8.8 million vs $7.7 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | FBLG | JAGX |
|---|---|---|
| Share price | $1.11 | $4.53 |
| Market cap | $7.72M | $8.81M |
| 1-day change | -2.63% | -9.40% |
| EPS (TTM) | $-5.01 | $-4,012.65 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $10.28 | $1,260.00 |
| 52-week low | $0.62 | $2.35 |
| Distance from 52-week high | -89.20% | -99.64% |
| Analyst consensus | none | — |
| Avg. price target upside | +1026.13% | — |
| Average volume | 204.43K | 2.01M |
| Shares outstanding | 6.96M | 1.95M |
| Employees | 15 | 47 |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About FibroBiologics
FBLG stock →FibroBiologics, Inc., a clinical-stage biotechnology company, engages in the development and commercialization of fibroblast-based therapies for patients suffering from chronic diseases. The company's product pipeline includes CYWC628 which has completed pre-clinical trial for the treatment of wound healing; CYMS101 which has completed Phase 1 trial for the treatment of multiple sclerosis; CybroCell for the treatment of degenerative disc disease; and CYPS317 for the treatment of psoriasis.
Healthcare · Biotechnology · 15 employees
About Jaguar Health
JAGX stock →Jaguar Health, Inc., a commercial-stage pharmaceuticals company, focuses on developing plant-based prescription medicines for people and animals with gastrointestinal distress. It operates through two segments, Animal Health and Human Health.
Healthcare · Biotechnology · 47 employees
FBLG vs JAGX FAQ
Which is bigger, FibroBiologics or Jaguar Health?
Jaguar Health (JAGX) is larger, with a market capitalization of $8.81M compared with $7.72M for FibroBiologics (FBLG).
Are FibroBiologics and Jaguar Health in the same industry?
Yes. Both are classified in the Biotechnology industry within the Healthcare sector.